Related references
Note: Only part of the references are listed.Dominant lethal mutations of topoisomerase II inhibitors etoposide and merbarone in male mice: a mechanistic study
Sabry M. Attia
ARCHIVES OF TOXICOLOGY (2012)
Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells
S. A. Bakheet et al.
MUTAGENESIS (2011)
Comparative aneugenicity of doxorubicin and its derivative idarubicin using fluorescence in situ hybridization techniques
Sabry M. Attia
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells
Sabry M. Attia
MUTAGENESIS (2010)
Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress
Sabry M. Attia et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Deleterious effects of reactive metabolites
Sabry M. Attia
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Redox regulation in cancer A double-edged sword with therapeutic potential
Asha Acharya et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans
Stefano Bonassi et al.
CARCINOGENESIS (2007)
Orthovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level
SM Attia et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2005)
Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level
T Sugiyama et al.
CANCER LETTERS (2004)
Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage
D Ravi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Secondary leukaemia after treating advanced bladder cancer with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and radiotherapy
C Theodore et al.
BJU INTERNATIONAL (2002)
Effect of dihydrokainate on the antitumor activity of doxorubicin
Y Sadzuka et al.
CANCER LETTERS (2002)
Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention
VB Pai et al.
DRUG SAFETY (2000)
Share Paper
